Breast Cancer: Targets and Therapy, 2017 Sandy Goyette,1,2 Yayun Liang,1,2 Benford Mafuvadze,1,2 Matthew T Cook,1,2 Moiz Munir,1,2 Salman M Hyder1,2 1Department of Biomedical Sciences, 2Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA Abstract: Clinical trials ...
Goyette S +5 more
doaj
PLoS ONEBackgroundUterine leiomyomas (often referred to as fibroids or myomas) are common benign, hormone-dependent tumors that grow in the uterus and occur in approximately 25% of reproductive age women, depending on selected population.
Samar Alkhrait +4 more
doaj +1 more source
Combined Continuous Ethinyl Estradiol/Norethindrone Acetate Does Not Improve Forearm Blood Flow in Postmenopausal Women at Risk for Cardiovascular Events: A Pilot Study [PDF]
, 2007 Claire S. Duvernoy +4 more
openalex +1 more source
A combination of norethindrone acetate and leuprolide acetate blocks the gonadotrophin-releasing hormone agonistic response and minimizes cyst formation during ovarian stimulation [PDF]
, 1996 Edward C. Ditkoff, Mark V. Sauer
openalex +1 more source
A Randomized Comparison of Continuous Combined Transdermal Delivery of Estradiol-Norethindrone Acetate and Estradiol Alone for Menopause [PDF]
, 1999 David F. Archer +4 more
openalex +1 more source
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, progesterone, and 17β-estradiol on thrombospondin-1 mRNA in Ishikawa cells [PDF]
, 2004 Sebastián Mirkin, David F. Archer
openalex +1 more source
Efficacy and Safety of a New 24-day Oral Contraceptive Regimen of Norethindrone Acetate 1 mg/Ethinyl Estradiol 20 μg Given for 24 Days Compared to a 21-day Regimen [PDF]
, 2005 Herman Ellman, David F. Archer
openalex +1 more source
The addition of norethindrone acetate to leuprolide acetate for ovarian suppression has no adverse effect on ovarian stimulation [PDF]
, 1997 Edward C. Ditkoff +4 more
openalex +1 more source